透過您的圖書館登入
IP:18.220.64.128
  • 期刊
  • OpenAccess

遺傳檢測與諮詢的倫理議題與執業準則-罹病傾向之遺傳檢測:以BRCA檢驗為例

The Ethical Issues and Practice Guidelines for Genetic Testing and Counseling-Pre-dispositional Genetic Testing Focusing on BRCA Testing

摘要


本文以BRCA檢驗為例,探討有關「罹病傾向之遺傳檢測與諮詢」所涉臨床情境、倫理議題與專業準則。作者首先呈現有關BRCA檢驗之基本醫學事實,並針對常見之臨床醫療決定與倫理問題進行分析,包括「乳癌基因檢驗對病患及家屬的利益」、「遺傳檢測諮詢的重要性」、「告知親屬遺傳資訊」、「孩童是否適合做BRCA基因檢驗」、「BRCA基因檢驗是否適用於產前診斷」、「可否不將檢驗結果納入病歷」。在回顧、歸納世界主流醫學團體與專業醫學會之報告書與執業倫理指引對上述議題之看法與建議之後,本文試擬出本土之「BRCA檢測與諮詢臨床執業倫理準則」(ethical guidelines for clinical practice)」,本準則已於臺大醫院內部進行討論修訂,之後將送國內相關專業醫學會作進一步之討論與確認。本研究期望透過廣泛之文獻回顧與倫理分析,為國內發展中之遺傳檢驗與諮詢服務,提供專業倫理之反思並建立實務工作之執業標準。

關鍵字

遺傳檢測 遺傳諮詢 BRCA 倫理準則

並列摘要


This paper, using the example of BRCA genetic testing, examines clinical situations, ethical issues and professional guidelines that are of concern when carrying out pre-dispositional genetic testing and counseling. The authors firstly present basic medical knowledge about BRCA testing, then analyze the commonly encountered clinical decisions and ethical problems. These include ”the benefit of testing for the BRCA gene for the patient and the family”, ”the importance of genetic counseling”, ”informing the relatives”, ”should children be tested?”, ”should BRCA testing be carried out during the antenatal period?” and ”should the result not be included in the medical chart?”. After reviewing a range of ethics reports and practice guidelines produced by a number of major professional bodies throughout the world regarding the above issues, the authors propose a set of indigenous ethical guidelines for BRCA genetic testing and counseling. The guidelines have been discussed and revised by geneticists and ethicists from National Taiwan University Hospital and will be sent to the relevant professional body for review and recognition. It is hoped that through this research we can help readers to reflect on professional ethics and from these thoughts help to establish practice guidelines for BRCA genetic testing.

參考文獻


Ethical Issues in Genetic Testing for BRCA1 and BRCA2
Feuer EJ,Wun LM,Boring CC(1993).The lifetime risk of developing breast cancer.J Natl Cancer Inst.85,892-897.
Robson ME(2002).Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.Cancer Control.9,457-465.
Markman M(2004).Genetic discrimination arising from cancer risk assessments: a societal dilemma.Cleve Clin J Med.71,12-18.
蘇怡寧(2002)。乳癌之BRCA1/BRCA2之基因分析。台灣醫學。6,706-713。

被引用紀錄


李明書(2017)。佛教經典視角的性別哲學研究〔博士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU201701825
楊君萍(2005)。藥物基因體學對生技醫藥產業生態影響之探討〔碩士論文,國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2005.00243
王瑤華(2017)。遺傳疾病對護理的衝擊及挑戰護理雜誌64(5),24-29。https://doi.org/10.6224/JN.000065
何怡萱(2015)。致病基因檢驗服務之基因資訊保護規範〔碩士論文,國立清華大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0016-0508201514083742

延伸閱讀